160 related articles for article (PubMed ID: 35837705)
1. Desmoid tumors: who, when and how to treat?
Mikhael R; Smith M; Tzanis D; Watson S; Miah AB; Bonvalot S
Curr Opin Oncol; 2022 Jul; 34(4):335-341. PubMed ID: 35837705
[TBL] [Abstract][Full Text] [Related]
2. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
Toulmonde M; Pulido M; Ray-Coquard I; Andre T; Isambert N; Chevreau C; Penel N; Bompas E; Saada E; Bertucci F; Lebbe C; Le Cesne A; Soulie P; Piperno-Neumann S; Sweet S; Cecchi F; Hembrough T; Bellera C; Kind M; Crombe A; Lucchesi C; Le Loarer F; Blay JY; Italiano A
Lancet Oncol; 2019 Sep; 20(9):1263-1272. PubMed ID: 31331699
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review.
Tsukamoto S; Takahama T; Mavrogenis AF; Tanaka Y; Tanaka Y; Errani C
Musculoskelet Surg; 2023 Mar; 107(1):7-18. PubMed ID: 35150408
[TBL] [Abstract][Full Text] [Related]
4. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis.
Palassini E; Frezza AM; Mariani L; Lalli L; Colombo C; Fiore M; Messina A; Casale A; Morosi C; Collini P; Stacchiotti S; Casali PG; Gronchi A
Cancer J; 2017; 23(2):86-91. PubMed ID: 28410293
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730
[TBL] [Abstract][Full Text] [Related]
6. [Low-dose methotrexate combined with vinorelbine for inoperable desmoid tumor: efficacy and the prognostic factors].
Fan Z; Li S; Fang Z; Liu J; Bai C; Xue R; Zhang L; Gao T
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):39-43. PubMed ID: 26806736
[TBL] [Abstract][Full Text] [Related]
7. Desmoid-type fibromatosis: toward a holistic management.
Penel N; Kasper B; van Der Graaf WTA
Curr Opin Oncol; 2021 Jul; 33(4):309-314. PubMed ID: 33973549
[TBL] [Abstract][Full Text] [Related]
8. Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study.
Nathenson MJ; Hu J; Ratan R; Somaiah N; Hsu R; DeMaria PJ; Catoe HW; Pang A; Subhawong TK; Amini B; Sweet K; Feister K; Malik K; Jagannathan J; Braschi-Amirfarzan M; Sheren J; Caldas Y; Moreno Tellez C; Rosenberg AE; Lazar AJ; Maki RG; Benedetto P; Cohen J; Trent JC; Ravi V; Patel S; Wilky BA
Clin Cancer Res; 2022 Sep; 28(18):4092-4104. PubMed ID: 35180772
[TBL] [Abstract][Full Text] [Related]
9. Successful low-dose chemotherapy using vinblastine and methotrexate for the treatment of an ileoanal pouch mesenteric desmoid tumor: report of a case.
Kono T; Tomita I; Chisato N; Matsuda M; Kakisaka A; Kasai S
Dis Colon Rectum; 2004 Feb; 47(2):246-9. PubMed ID: 15043298
[TBL] [Abstract][Full Text] [Related]
10. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial.
Skapek SX; Ferguson WS; Granowetter L; Devidas M; Perez-Atayde AR; Dehner LP; Hoffer FA; Speights R; Gebhardt MC; Dahl GV; Grier HE;
J Clin Oncol; 2007 Feb; 25(5):501-6. PubMed ID: 17290057
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate and Vinblastine or Vinorelbine Remain Useful Treatments for Desmoid-Type Fibromatosis 30 Years Later.
Schuetze SM
Cancer J; 2017; 23(2):92-94. PubMed ID: 28410294
[No Abstract] [Full Text] [Related]
12. Activity of Sorafenib against desmoid tumor/deep fibromatosis.
Gounder MM; Lefkowitz RA; Keohan ML; D'Adamo DR; Hameed M; Antonescu CR; Singer S; Stout K; Ahn L; Maki RG
Clin Cancer Res; 2011 Jun; 17(12):4082-90. PubMed ID: 21447727
[TBL] [Abstract][Full Text] [Related]
13. Effective treatment of multifocal aggressive fibromatosis with low-dose chemotherapy.
Caglar K; Ozyönüm H; Akalin M; Balci S
Turk J Pediatr; 2006; 48(4):365-8. PubMed ID: 17290575
[TBL] [Abstract][Full Text] [Related]
14. [Systemic treatment for management of aggressive fibromatosis in both adult and children: Level of evidence and unsolved questions].
Penel N; Ryckewaert T; Orbach D
Bull Cancer; 2020 Mar; 107(3):375-380. PubMed ID: 31812284
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Physician's Systemic Treatment Preferences for Patients with Advanced Desmoid-Type Fibromatosis: Experience-Based Medicine in the Absence of High-Level Evidence.
Schöffski P; Requilé A; van Cann T
Oncol Res Treat; 2018; 41(4):214-219. PubMed ID: 29562221
[TBL] [Abstract][Full Text] [Related]
16. Desmoid tumours stalled by sorafenib.
Wrighton KH
Nat Rev Clin Oncol; 2019 Apr; 16(4):209. PubMed ID: 30664677
[No Abstract] [Full Text] [Related]
17. Active surveillance and emerging medical treatment options for desmoid: when and for whom?
Bonvalot S; Miah A; Kasper B
Curr Opin Oncol; 2024 May; ():. PubMed ID: 38726846
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children.
Skapek SX; Hawk BJ; Hoffer FA; Dahl GV; Granowetter L; Gebhardt MC; Ferguson WS; Grier HE
J Clin Oncol; 1998 Sep; 16(9):3021-7. PubMed ID: 9738571
[TBL] [Abstract][Full Text] [Related]
19. A Novel Method to Treat Progressive Desmoid Tumors Involving Neurovascular Bundles: A Retrospective Cohort Study.
Yin JQ; Fu YW; Gao ZH; Zou CY; Xie XB; Wang B; Zhong ZH; Huang G; Shen JN
Neurosurgery; 2021 May; 88(6):1095-1102. PubMed ID: 33556169
[TBL] [Abstract][Full Text] [Related]
20. Emerging Role of Multikinase Inhibitors in Desmoid Tumor Management.
Penel N; Ryckewaert T; Le Deley MC
Am J Clin Oncol; 2019 Dec; 42(12):958. PubMed ID: 31764064
[No Abstract] [Full Text] [Related]
[Next] [New Search]
